Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • mike_m
    Junior Member
    • Jan 2014
    • 1

    #1

    DESeq 2 shrinkage Wald test vs. LR test

    This is more a conceptual question to those in the know (particularly Mike Love, Simon Anders and Wolfgang Huber if you're reading).

    I'm doing a slightly quick a dirty analysis using DESeq2 to test for interactions between 3 biological conditions and expression changes over time (only between 2 time points, so one hope issues of sphericity/autocorrelation do not become an issue).

    The current implementation using the Wald test will, by default, apply a beta prior to moderate the effect sizes from the GLM. I understand the default implementation as the Wald test uses the effect size estimates to calculate the p-value that the effect is different from zero. The likelihood ratio test does not require an accurate effect size estimate as I understand it, therefore I assume that this is the reason there is no default implementation for the effect size estimate moderation, or is there a mathematical reason for this?

    Also, is there a way to extract the pre-moderated effect sizes in order to compare them to the moderated ones (regardless of which test is applied?).

    Thanks in advance.
  • Michael Love
    Senior Member
    • Jul 2013
    • 333

    #2
    hi Mike,

    Here's a post where I talk a bit about why we used the moderation of effect sizes only for the Wald test:

    Discussion of next-gen sequencing related bioinformatics: resources, algorithms, open source efforts, etc


    So it's default to have shrinkage with the Wald test, and no shrinkage with the LRT. Although both defaults can be overridden.

    Note that with interaction terms in the model, the shrinkage is only applied to the interaction terms (discussed in ?nbinomWaldTest and in the Methods of the preprint).

    There is a way to extract pre-moderated effect sizes in DESeq2 version 1.6, which will be released in October with Bioconductor v3.0. You simply:

    Code:
    results(dds, addMLE=TRUE)

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
      by SEQadmin2



      CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

      Despite this, “CRISPR helped turn genome editing from a specialized technique into
      ...
      07-31-2026, 11:01 AM
    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 08-06-2026, 07:41 AM
    0 responses
    20 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 08-03-2026, 10:13 AM
    0 responses
    33 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-31-2026, 02:55 AM
    0 responses
    43 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-24-2026, 12:17 PM
    0 responses
    26 views
    0 reactions
    Last Post SEQadmin2  
    Working...